the money man, page-3

Very interesting appointment. David was certainly very bullish about TPT when he was at Hartley's, and his notes got a lot of coverage on HC.

He's been at Argonaut most recently (who have been an advisor, and have a fair few shares in TPT), so it has to be assumed that he has effectively been 'placed' into the MD role. For long-term holders this will ring some slight alarm bells, but you'd have to think that increasing shareholder value in the short term will be front of mind.